SCHEDULE 13G/A: BlackRock Discloses 5.3% Passive Stake in INOVIO PHARMACEUTICALS
Beneficial Ownership Report
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.3% beneficial ownership stake in INOVIO PHARMACEUTICALS INC as of December 31, 2024.
Summary
- BlackRock, Inc. reported beneficial ownership of 1,908,511 shares of INOVIO PHARMACEUTICALS INC common stock.
- This ownership represents 5.3% of the total outstanding common stock of INOVIO PHARMACEUTICALS INC.
- BlackRock, Inc. holds sole voting power over 1,873,276 shares and sole dispositive power over 1,908,511 shares.
- The filing is an Amendment No. 1 to Schedule 13G, indicating a previous filing existed for this stake.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual, regulatory filing disclosing a passive ownership stake, which is neutral in sentiment.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of a passive institutional investment, reflecting BlackRock's portfolio management activities rather than a specific strategic move related to the biotechnology or pharmaceutical industry trends.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership in the company.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | Date of event which requires filing of this statement |
| 2025-01-21 | Date of Power of Attorney execution |
| 2025-02-05 | Date of Schedule 13G filing signature |
Keywords
BlackRock, INOVIO PHARMACEUTICALS, Schedule 13G, beneficial ownership, common stock, institutional investor, passive stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.